10x Genomics
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. 10x Genomics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 20% to $618,727,000. Profit margin reached -41%. Total operating expenses were $674,949,000.

Profit Margin

10x Genomics, Inc. (NASDAQ:TXG): Profit margin
2017 71.08M -18.76M -26.39%
2018 146.31M -112.48M -76.88%
2019 245.89M -31.25M -12.71%
2020 298.84M -542.73M -181.61%
2021 490.49M -58.22M -11.87%
2022 516.40M -166M -32.15%
2023 618.72M -255.09M -41.23%

TXG Income Statement (2017 – 2023)

2023 2022 2021 2020 2019 2018 2017
Revenue
Revenue
618.72M516.40M490.49M298.84M245.89M146.31M71.08M
Cost of revenue
209.41M120.38M74.09M58.46M61.03M28.66M10.56M
Gross profit
409.31M396.02M416.39M240.37M184.86M117.65M60.52M
Operating exp.
Research and development
270.33M265.66M211.75M123.37M83.09M47.53M32.16M
Selling and marketing
3.3M3.7M4.7M1.9M1.5M0200K
Total operating expenses
674.94M563.96M469.31M325.70M213.93M135.47M78.9M
Operating income
-265.32M-167.94M-52.91M-85.32M-29.07M-110.76M-18.37M
Other income (expenses), net
16.56M5.97M-802K-449.15M-1.96M-93.19M-366K
Income before tax
-248.76M-161.97M-53.71M-534.47M-31.03M-112.39M-18.74M
Income tax expense
6.33M4.02M4.50M8.25M218K87K21K
Net income
-255.09M-166M-58.22M-542.73M-31.25M-112.48M-18.76M
Earnings per share
Basic EPS
-2.18-1.46-0.53-5.37-0.8-8.4-1.62
Diluted EPS
-2.18-1.46-0.53-5.37-0.8-8.4-1.62
Data sourceData sourceData sourceData sourceData source